Microbes without frontiers: Severe haemolytic-uraemic syndrome due to e coli O104:H4

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Binks, Sophie ^a   Regan, Kate ^b   Richenberg, Jonathan ^a,b   Chevassut, Tim ^b  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CREATININE; FIBRINOGEN; FRESH FROZEN PLASMA; LACTATE DEHYDROGENASE;

ACUTE KIDNEY FAILURE; ADULT; ANURIA; ARTICLE; BLOODY DIARRHEA; CASE REPORT; CLINICAL FEATURE; CONFUSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESCHERICHIA COLI; FLUID RESUSCITATION; FOLLOW UP; HEMOFILTRATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTESTINE SOUND; MALE; MEDICAL HISTORY; NEUTROPHILIA; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; TREATMENT RESPONSE;

EID: 84872743797     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006896     Document Type: Article

References (19)

1. Garg AX, Suri RS, Barrowman N, et al. Long term renal prognosis of diarrhea-associated haemolytic-uremic syndrome. A systematic review, meta-analysis and meta-regression. JAMA 2003;290:1360-70. (Pubitemid 37442634)
2. Michael M, Elliott EJ, Ridley GF, et al. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopaenic purpura. Cochrane Database Syst Rev 2009;(1):CD003595.
3. Health Protection Agency. E. coli O157 annual totals (on-line). 2012. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb-C/1249113624846 (accessed 4 Jun 2012).
4. Zhang X, McDaniel AD, Wolf LE, et al. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production and death in mice. J Infect Dis 2000;181:664-70. (Pubitemid 30131837)
5. Rasko DA, Webster DR, Sahl JW, et al. Origins of the E. coli strain causing an outbreak of haemolytic-uremic syndrome in Germany. N Engl J Med 2011;365:709-11.
6. Colic E, Dieperink H, Titlestad K, et al. Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet 2011;378:1089-93.
7. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005;365:1073-86. (Pubitemid 40386785)
8. Greinacher A, Friesecke S, Abel P, et al. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Lancet 2011;378:1166-73.
9. McGannon CM, Fuller CA, Weiss AA. Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob Agents Chemother 2010;54:3790-8.
10. Kimmitt PT, Harwood CR, Barer MR. Induction of type 2 Shiga toxin synthesis in Eschericia coli O157 by 4-quinolones. Lancet 1999;353:1588-9. (Pubitemid 29219214)
11. Dumitrescu O, Badiou C, Bes M, et al. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect 2008;14:384-8. (Pubitemid 351356532)
12. Dumitrescu O, Choudhury P, Boisset S, et al. lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob Agents Chemother 2011;55:3261-71.
13. Bielaszewska M, Idelevich EA, Zhang W, et al. Effects of antibiotics on Shiga- toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother 2012;56:3277-82.
14. Wong CS, Jelacic S, Habeeb RL, et al. The risk of the haemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000;342:1930-6. (Pubitemid 30419087)
15. Allan DS, Thompson CM, Barr RM, et al. Ciprofloxacin-associated haemolytic-uremic syndrome. Ann Pharmacother 2002;36:1000-2.
16. Minne J, Nitschke M, Stingele R, et al. Validation of treatment strategies for enterohaemorrhagic Escherechia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012;345:e4565.
17. Artunc F. Treating shiga toxin induced haemolytic uraemic syndrome. BMJ 2012;345:e4598.
18. British National Formulary. BNF 63. London: BMJ group and RPS publishing, 2012.
19. Lapeyraque AL, Malina M, Fremeaux-Bacchi V, et al. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 2011;364:2561-3.